Aaron Lohr Named Society’s Chief Communications Officer

A Lohr

The Endocrine Society’s director, media relations, Aaron Lohr, has been promoted to the position of Chief Communications Officer.

In his new capacity, Lohr will serve as the Society’s chief storyteller and will be responsible for developing and implementing a content-driven comprehensive communications and marketing strategy. He will also be responsible for the Society’s digital strategy, web destinations, email, social, and all online communications and integration.

Lohr joined the Society in 2007 and helped build a media relations program that garnered record media coverage of the Society year after year. His media training sessions have helped the Society to develop a strong stable of expert spokespeople who are sought after by journalists all over the world. He’s secured media coverage in top tier outlets including the New York Times, Wall Street Journal, BBC News, CNN, and Le Monde.

Lohr also developed the Society’s message center which assures the organization delivers strategic, memorable, and consistent communications across the Society’s channels and to each of its audiences.

“Aaron’s leadership, forward-looking strategic approach, and demonstrated commitment to integrated communications will strengthen the Society as he steps into the roles of chief digital strategist, storyteller, and proprietor of the voice of the Society and its members,” says Society CEO Barbara Byrd Keenan.

Prior to joining the Society, Lohr served as manager of public relations for ORC Macro where his many clients included the Substance Abuse and Mental Health Services Administration, the Maryland Department of Health and Mental Hygiene, the Office of the Surgeon General, and the National Eye Institute.

 

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in